CTLA-4-directed Blocking Antibody [EPC]

CTLA-4-directed Blocking Antibody [EPC] was reported 48231 times

Drugs of the CTLA-4-directed Blocking Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HYPOPHYSITIS 1102 0.5474
1 LYMPHOCYTIC HYPOPHYSITIS 148 0.5362
2 IMMUNE-MEDIATED HYPOPITUITARISM 16 0.4848
3 AUTOIMMUNE COLITIS 290 0.4496
4 IMMUNE-MEDIATED UVEITIS 82 0.4481
5 IMMUNE-MEDIATED HYPOPHYSITIS 199 0.4412
6 IMMUNE-MEDIATED GASTROINTESTINAL DISORDER 17 0.3953
7 IMMUNE-MEDIATED ENTEROCOLITIS 1330 0.3613
8 IMMUNE-MEDIATED DERMATITIS 347 0.3442
9 ENDOCRINE TOXICITY 35 0.3431
10 IMMUNE-MEDIATED ENDOCRINOPATHY 51 0.3400
11 IMMUNE-MEDIATED HEPATITIS 608 0.2975
12 IMMUNE-MEDIATED THYROIDITIS 135 0.2733
13 HYPOPITUITARISM 466 0.2677
14 IMMUNE-MEDIATED HYPERTHYROIDISM 67 0.2638
15 IMMUNE-MEDIATED HEPATIC DISORDER 514 0.2633
16 IMMUNE-MEDIATED CYSTITIS 29 0.2522
17 AUTOIMMUNE NEPHRITIS 54 0.2455
18 IMMUNE-MEDIATED NEPHRITIS 113 0.2409
19 AUTOIMMUNE DERMATITIS 36 0.2384
20 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 187 0.2346
21 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 205 0.2335
22 FULMINANT TYPE 1 DIABETES MELLITUS 236 0.2289
23 LEUKODERMA 45 0.2261
24 IMMUNE-MEDIATED ENCEPHALOPATHY 20 0.2247
25 ADRENALITIS 24 0.2243
26 IMMUNE-MEDIATED LUNG DISEASE 404 0.2214
27 IMMUNE-MEDIATED PANCREATITIS 81 0.2126
28 IMMUNE-MEDIATED ARTHRITIS 80 0.2100
29 IMMUNE-MEDIATED ENCEPHALITIS 111 0.2098
30 IMMUNE-MEDIATED NEUROLOGICAL DISORDER 18 0.2069
31 IMMUNE-MEDIATED CHOLANGITIS 74 0.2061
32 IMMUNE-MEDIATED MYOCARDITIS 333 0.2061
33 IMMUNE-MEDIATED HYPOTHYROIDISM 221 0.1959
34 IMMUNE-MEDIATED OESOPHAGITIS 14 0.1944
35 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED 13 0.1940
36 IMMUNE-MEDIATED MYASTHENIA GRAVIS 63 0.1938
37 PITUITARY ENLARGEMENT 37 0.1814
38 AUTOIMMUNE ARTHRITIS 28 0.1783
39 IMMUNE-MEDIATED GASTRITIS 34 0.1771
40 BRAIN RADIATION NECROSIS 13 0.1757
41 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 40 0.1754
42 VOGT-KOYANAGI-HARADA DISEASE 35 0.1591
43 IMMUNE-MEDIATED RENAL DISORDER 65 0.1570
44 SECONDARY ADRENOCORTICAL INSUFFICIENCY 237 0.1568
45 SILENT THYROIDITIS 22 0.1528
46 MENINGORADICULITIS 16 0.1481
47 LIVER CARCINOMA RUPTURED 36 0.1429
48 IMMUNE-MEDIATED PNEUMONITIS 33 0.1410
49 NEUROFIBROSARCOMA 14 0.1359
50 AUTOIMMUNE LUNG DISEASE 15 0.1271
51 HYPOTHALAMO-PITUITARY DISORDER 184 0.1263
52 AUTOIMMUNE NEUROPATHY 16 0.1240
53 PANCREATIC TOXICITY 15 0.1240
54 BLOOD CORTICOTROPHIN DECREASED 60 0.1230
55 IMMUNOTOXICITY 14 0.1228
56 THYROIDITIS 365 0.1214
57 IMMUNE-MEDIATED NEUROPATHY 18 0.1161
58 AUTOIMMUNE MYOCARDITIS 25 0.1142
59 SECONDARY HYPOTHYROIDISM 17 0.1111
60 TUMOUR HYPERPROGRESSION 26 0.1048
61 GLUCOCORTICOID DEFICIENCY 43 0.1017
62 AUTOIMMUNE HYPOTHYROIDISM 23 0.0966
63 AUTOIMMUNE PANCREATITIS 48 0.0949
64 IMMUNE-MEDIATED ADVERSE REACTION 144 0.0938
65 CENTRAL HYPOTHYROIDISM 31 0.0937
66 CRYPTITIS 13 0.0935
67 ORBITAL MYOSITIS 14 0.0921
68 ADRENAL INSUFFICIENCY 1043 0.0859
69 INTRACRANIAL TUMOUR HAEMORRHAGE 32 0.0827
70 TUMOUR PSEUDOPROGRESSION 88 0.0804
71 VITILIGO 186 0.0792
72 ENTEROCOLITIS 457 0.0791
73 ENDOCRINE DISORDER 101 0.0787
74 TRI-IODOTHYRONINE FREE DECREASED 19 0.0745
75 NON-SMALL CELL LUNG CANCER 345 0.0719
76 MALIGNANT NEOPLASM OLIGOPROGRESSION 14 0.0704
77 CORTISOL DECREASED 80 0.0700
78 METASTATIC MALIGNANT MELANOMA 154 0.0670
79 RADIATION NECROSIS 38 0.0663
80 COLITIS 2511 0.0662
81 PRIMARY HYPOTHYROIDISM 14 0.0660
82 BILIARY TRACT INFECTION 41 0.0659
83 TYPE 1 DIABETES MELLITUS 380 0.0630
84 ADRENOCORTICAL INSUFFICIENCY ACUTE 121 0.0620
85 AUTOIMMUNE HEPATITIS 417 0.0599
86 MYASTHENIC SYNDROME 46 0.0594
87 PRIMARY ADRENAL INSUFFICIENCY 18 0.0590
88 SEROUS RETINAL DETACHMENT 49 0.0585
89 IMMUNE-MEDIATED MYOSITIS 157 0.0569
90 NON-SMALL CELL LUNG CANCER RECURRENT 16 0.0565
91 ADRENAL DISORDER 108 0.0562
92 THROMBOPHLEBITIS MIGRANS 19 0.0559
93 MYOCARDITIS 608 0.0530
94 MELANOMA RECURRENT 21 0.0499
95 CYTOMEGALOVIRUS ENTEROCOLITIS 38 0.0494
96 TUMOUR ASSOCIATED FEVER 20 0.0489
97 APOPTOSIS 15 0.0485
98 SECONDARY HYPOGONADISM 16 0.0485
99 NEPHRITIS 160 0.0479
100 LIMBIC ENCEPHALITIS 13 0.0471
101 ENTEROCOLITIS INFECTIOUS 43 0.0466
102 ENCEPHALITIS AUTOIMMUNE 60 0.0456
103 BLOOD CORTICOTROPHIN INCREASED 13 0.0450
104 HYPERTHYROIDISM 619 0.0427
105 MYOSITIS 382 0.0425
106 MALIGNANT NEOPLASM PROGRESSION 4144 0.0404
107 THYROXINE FREE DECREASED 22 0.0389
108 PNEUMONITIS 1059 0.0389
109 TUMOUR PAIN 51 0.0387
110 THYROTOXIC CRISIS 43 0.0378
111 RADIATION PNEUMONITIS 80 0.0373
112 CYTOKINE RELEASE SYNDROME 741 0.0369
113 AMYLASE INCREASED 136 0.0368
114 CYTOKINE STORM 24 0.0350
115 PARVOVIRUS INFECTION 14 0.0347
116 DIABETIC KETOSIS 13 0.0342
117 ENTEROCOLITIS HAEMORRHAGIC 49 0.0331
118 DISSEMINATED MUCORMYCOSIS 13 0.0330
119 MYASTHENIA GRAVIS 260 0.0322
120 EXPOSURE VIA BODY FLUID 25 0.0318
121 LIPASE INCREASED 238 0.0310
122 ENCEPHALITIS 212 0.0306
123 AUTOIMMUNE HAEMOLYTIC ANAEMIA 105 0.0306
124 MENINGITIS ASEPTIC 135 0.0300
125 PERIPHERAL MOTOR NEUROPATHY 42 0.0300
126 AUTOIMMUNE THYROIDITIS 111 0.0293
127 LICHENOID KERATOSIS 67 0.0293
128 PRERENAL FAILURE 41 0.0291
129 GUILLAIN-BARRE SYNDROME 138 0.0285
130 BILE DUCT STENOSIS 34 0.0284
131 HYPOTHYROIDISM 906 0.0283
132 DEMYELINATING POLYNEUROPATHY 29 0.0282
133 HEPATITIS 720 0.0281
134 IRIS ADHESIONS 14 0.0273
135 METASTASES TO ADRENALS 25 0.0271
136 DUODENITIS 83 0.0270
137 TUMOUR HAEMORRHAGE 77 0.0270
138 METASTASES TO CENTRAL NERVOUS SYSTEM 339 0.0263
139 METASTASES TO SKIN 27 0.0261
140 AUTOIMMUNE DISORDER 255 0.0261
141 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 194 0.0258
142 LARGE INTESTINE PERFORATION 178 0.0256
143 HEPATOBILIARY DISEASE 16 0.0256
144 GIANT CELL ARTERITIS 21 0.0253
145 ENTERITIS 158 0.0247
146 PANCREATIC ENZYMES INCREASED 36 0.0246
147 PRESCRIBED OVERDOSE 462 0.0239
148 EROSIVE DUODENITIS 19 0.0238
149 SIALOADENITIS 32 0.0235
150 BLOOD CORTISOL DECREASED 15 0.0234
151 PULMONARY TOXICITY 165 0.0233
152 CHORIORETINITIS 15 0.0233
153 CHOLANGITIS SCLEROSING 47 0.0229
154 PULMONARY SEPSIS 33 0.0227
155 CHOLANGITIS 138 0.0222
156 TUMOUR NECROSIS 23 0.0218
157 PULMONARY SARCOIDOSIS 24 0.0214
158 BLOOD THYROID STIMULATING HORMONE DECREASED 97 0.0213
159 PEMPHIGOID 161 0.0213
160 IRIDOCYCLITIS 67 0.0212
161 LYMPHANGIOSIS CARCINOMATOSA 22 0.0211
162 HYPOGONADISM 21 0.0208
163 GLOMERULONEPHRITIS MINIMAL LESION 15 0.0207
164 MYELITIS 32 0.0206
165 GASTROINTESTINAL TOXICITY 99 0.0206
166 INTESTINAL PERFORATION 231 0.0206
167 SKIN TOXICITY 114 0.0202
168 IMMUNE THROMBOCYTOPENIA 92 0.0201
169 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 25 0.0201
170 OVERLAP SYNDROME 14 0.0200
171 CHRONIC GASTRITIS 45 0.0199
172 POLYMYALGIA RHEUMATICA 63 0.0198
173 HYPOPARATHYROIDISM 15 0.0196
174 CAPILLARY LEAK SYNDROME 40 0.0193
175 POLYMYOSITIS 34 0.0192
176 CHOLANGITIS ACUTE 14 0.0185
177 TEMPORAL ARTERITIS 17 0.0184
178 ALPHA 1 FOETOPROTEIN INCREASED 13 0.0183
179 CREATINE KINASE INCREASED 14 0.0182
180 METASTASES TO PLEURA 19 0.0181
181 UVEITIS 243 0.0179
182 METASTASES TO MENINGES 40 0.0176
183 DIABETIC KETOACIDOSIS 421 0.0175
184 MALIGNANT PLEURAL EFFUSION 29 0.0172
185 NON-SMALL CELL LUNG CANCER METASTATIC 15 0.0171
186 MYELITIS TRANSVERSE 24 0.0170
187 THYROID DISORDER 261 0.0169
188 STEROID DIABETES 25 0.0167
189 LIVER DISORDER 737 0.0166
190 GASTROINTESTINAL PERFORATION 69 0.0166
191 HEPATIC FUNCTION ABNORMAL 616 0.0165
192 ERYTHEMA MULTIFORME 148 0.0159
193 VITH NERVE PARALYSIS 18 0.0158
194 RASH MACULO-PAPULAR 350 0.0157
195 HEPATIC INFECTION 20 0.0157
196 CANCER PAIN 40 0.0156
197 RADIATION SKIN INJURY 18 0.0155
198 FACIAL PARALYSIS 132 0.0155
199 INTENTIONAL PRODUCT USE ISSUE 1352 0.0154
200 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 17 0.0152
201 LYMPHADENOPATHY MEDIASTINAL 29 0.0151
202 TROPONIN I INCREASED 25 0.0150
203 RHEUMATIC DISORDER 29 0.0150
204 HYPERSENSITIVITY PNEUMONITIS 17 0.0149
205 PANCREATIC FAILURE 26 0.0147
206 PREGNANCY ON CONTRACEPTIVE 21 0.0144
207 CYTOMEGALOVIRUS COLITIS 33 0.0143
208 MENINGITIS 94 0.0141
209 RADICULOPATHY 37 0.0140
210 DERMATOMYOSITIS 35 0.0138
211 HYPERCALCAEMIA 170 0.0138
212 IMMUNE THROMBOCYTOPENIC PURPURA 38 0.0134
213 POLYARTHRITIS 70 0.0133
214 METASTASES TO LUNG 153 0.0132
215 LICHEN PLANUS 30 0.0129
216 TUBULOINTERSTITIAL NEPHRITIS 241 0.0128
217 HEPATOTOXICITY 286 0.0128
218 HYPERTRANSAMINASAEMIA 89 0.0128
219 APLASIA PURE RED CELL 44 0.0128
220 INTERSTITIAL LUNG DISEASE 614 0.0127
221 TROPONIN T INCREASED 16 0.0126
222 INFECTIOUS PLEURAL EFFUSION 19 0.0125
223 SARCOIDOSIS 59 0.0124
224 CARDIAC TAMPONADE 59 0.0124
225 THYROID FUNCTION TEST ABNORMAL 51 0.0123
226 DISSEMINATED INTRAVASCULAR COAGULATION 172 0.0122
227 LUNG OPACITY 32 0.0121
228 MEGACOLON 19 0.0121
229 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 17 0.0118
230 HEPATITIS FULMINANT 35 0.0118
231 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 13 0.0117
232 PERIPHERAL SENSORY NEUROPATHY 68 0.0116
233 CELL DEATH 23 0.0116
234 CYTOMEGALOVIRUS TEST POSITIVE 20 0.0112
235 DIABETES INSIPIDUS 27 0.0112
236 ENTERITIS INFECTIOUS 19 0.0112
237 PERIPHERAL SENSORIMOTOR NEUROPATHY 14 0.0111
238 EMBOLISM 92 0.0111
239 TUMOUR LYSIS SYNDROME 97 0.0110
240 ESCHERICHIA TEST POSITIVE 13 0.0109
241 HEPATIC CYTOLYSIS 138 0.0108
242 DIABETIC METABOLIC DECOMPENSATION 15 0.0108
243 DERMATITIS 221 0.0105
244 PHYSICAL DECONDITIONING 27 0.0105
245 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 40 0.0105
246 DRUG ERUPTION 185 0.0104
247 ADVERSE EVENT 959 0.0104
248 TROPONIN INCREASED 79 0.0104
249 METASTASES TO LYMPH NODES 70 0.0104
250 HYPOALBUMINAEMIA 80 0.0103
251 HYPONATRAEMIA 577 0.0102
252 URINARY TRACT OBSTRUCTION 24 0.0101
253 NON-CARDIAC CHEST PAIN 32 0.0101
254 ATRIOVENTRICULAR BLOCK COMPLETE 66 0.0099
255 GRANULOMA 34 0.0098
256 PNEUMONIA BACTERIAL 90 0.0098
257 ASPARTATE AMINOTRANSFERASE INCREASED 518 0.0097
258 TOXIC EPIDERMAL NECROLYSIS 148 0.0097
259 BRAIN OEDEMA 122 0.0096
260 PERFORMANCE STATUS DECREASED 45 0.0096
261 NEPHROTIC SYNDROME 66 0.0096
262 SMALL INTESTINAL PERFORATION 18 0.0096
263 COLITIS MICROSCOPIC 45 0.0095
264 ORGANISING PNEUMONIA 47 0.0095
265 SMALL INTESTINAL HAEMORRHAGE 19 0.0094
266 GASTRITIS HAEMORRHAGIC 14 0.0094
267 ADENOCARCINOMA 21 0.0094
268 ALVEOLITIS 13 0.0092
269 DRUG-INDUCED LIVER INJURY 288 0.0092
270 POLYNEUROPATHY 109 0.0091
271 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 21 0.0090
272 TRANSAMINASES INCREASED 200 0.0090
273 PROCTITIS 25 0.0089
274 DEAFNESS BILATERAL 15 0.0088
275 PNEUMOCYSTIS JIROVECII PNEUMONIA 88 0.0088
276 HYPERGLYCAEMIA 318 0.0087
277 SUDDEN DEATH 92 0.0087
278 HYPOPHOSPHATAEMIA 64 0.0087
279 EMPYEMA 17 0.0085
280 MULTIPLE ORGAN DYSFUNCTION SYNDROME 238 0.0084
281 HAEMOLYTIC ANAEMIA 75 0.0084
282 METASTASES TO SPINE 28 0.0083
283 ALANINE AMINOTRANSFERASE INCREASED 509 0.0083
284 HEPATIC FAILURE 249 0.0083
285 PRODUCT PREPARATION ISSUE 54 0.0082
286 MALIGNANT MELANOMA 110 0.0082
287 METASTATIC RENAL CELL CARCINOMA 15 0.0082
288 PAPILLOEDEMA 37 0.0082
289 SKIN DISORDER 273 0.0082
290 BLOOD THYROID STIMULATING HORMONE INCREASED 75 0.0081
291 PERICARDIAL EFFUSION 188 0.0081
292 PLEURAL EFFUSION 491 0.0081
293 CHOLECYSTITIS 96 0.0081
294 PORTAL VEIN THROMBOSIS 26 0.0080
295 HEPATITIS ACUTE 52 0.0080
296 PRESCRIBED UNDERDOSE 159 0.0080
297 CACHEXIA 41 0.0080
298 LYMPHOCYTE COUNT INCREASED 26 0.0080
299 CUTANEOUS VASCULITIS 29 0.0079
300 GASTROINTESTINAL OEDEMA 14 0.0079
301 BILE DUCT OBSTRUCTION 15 0.0079
302 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 81 0.0079
303 APLASTIC ANAEMIA 41 0.0078
304 ILEUS PARALYTIC 35 0.0078
305 IGA NEPHROPATHY 13 0.0078
306 CHOLESTASIS 148 0.0077
307 HEPATORENAL SYNDROME 13 0.0077
308 METASTASIS 55 0.0077
309 RASH MORBILLIFORM 21 0.0076
310 METASTASES TO LIVER 133 0.0076
311 STEVENS-JOHNSON SYNDROME 168 0.0075
312 METASTASES TO PERITONEUM 19 0.0075
313 HISTIOCYTOSIS HAEMATOPHAGIC 22 0.0074
314 HEPATOCELLULAR INJURY 105 0.0074
315 GLOMERULONEPHRITIS 18 0.0073
316 ESCHERICHIA URINARY TRACT INFECTION 31 0.0073
317 OESOPHAGITIS 79 0.0072
318 GASTROINTESTINAL NECROSIS 21 0.0072
319 HEPATIC ENCEPHALOPATHY 67 0.0072
320 OPTIC NEURITIS 65 0.0071
321 FAILURE TO THRIVE 37 0.0071
322 ENCEPHALOPATHY 174 0.0071
323 ILEUS 88 0.0071
324 LUNG INFECTION 110 0.0071
325 BLOOD BILIRUBIN INCREASED 191 0.0071
326 CLOSTRIDIUM DIFFICILE COLITIS 74 0.0070
327 MYOPATHY 60 0.0069
328 CLOSTRIDIUM TEST POSITIVE 15 0.0068
329 EYELID PTOSIS 69 0.0068
330 GASTRITIS 178 0.0068
331 PSEUDOMEMBRANOUS COLITIS 15 0.0067
332 PYREXIA 2324 0.0067
333 HEPATIC LESION 29 0.0067
334 RETINOPATHY 25 0.0067
335 ATELECTASIS 64 0.0066
336 ASCITES 194 0.0066
337 SEPSIS 736 0.0066
338 METASTASES TO BONE 108 0.0066
339 OESOPHAGEAL CANDIDIASIS 26 0.0065
340 HYPOKALAEMIA 301 0.0065
341 LOCALISED OEDEMA 30 0.0065
342 LIVER ABSCESS 21 0.0065
343 LIVER FUNCTION TEST INCREASED 138 0.0064
344 SPINAL CORD COMPRESSION 25 0.0064
345 DERMATITIS ACNEIFORM 39 0.0064
346 VENOUS THROMBOSIS 25 0.0064
347 HEPATITIS CHOLESTATIC 38 0.0063
348 ERYTHEMA NODOSUM 22 0.0063
349 SMALL INTESTINAL OBSTRUCTION 77 0.0062
350 ACUTE KIDNEY INJURY 952 0.0062
351 ESCHERICHIA SEPSIS 18 0.0062
352 LYMPHADENITIS 15 0.0062
353 NEOPLASM RECURRENCE 21 0.0062
354 AGRANULOCYTOSIS 115 0.0062
355 SEPTIC SHOCK 269 0.0062
356 BACTERAEMIA 73 0.0061
357 BLOOD LACTATE DEHYDROGENASE INCREASED 97 0.0061
358 PATHOLOGICAL FRACTURE 31 0.0061
359 DIARRHOEA HAEMORRHAGIC 57 0.0061
360 TOXIC SKIN ERUPTION 61 0.0061
361 DERMATITIS EXFOLIATIVE GENERALISED 21 0.0060
362 C-REACTIVE PROTEIN INCREASED 217 0.0060
363 STRESS CARDIOMYOPATHY 34 0.0058
364 CHOLESTATIC LIVER INJURY 13 0.0058
365 VIITH NERVE PARALYSIS 20 0.0058
366 LARGE INTESTINAL HAEMORRHAGE 13 0.0058
367 DEATH 4988 0.0058
368 PANNICULITIS 14 0.0058
369 DEHYDRATION 760 0.0057
370 THROMBOTIC THROMBOCYTOPENIC PURPURA 20 0.0057
371 DUODENAL ULCER 40 0.0057
372 JAUNDICE CHOLESTATIC 20 0.0057
373 MIXED LIVER INJURY 17 0.0056
374 EOSINOPHIL COUNT INCREASED 47 0.0056
375 OESOPHAGEAL STENOSIS 16 0.0056
376 HYPERURICAEMIA 23 0.0056
377 EOSINOPHILIA 98 0.0056
378 FEBRILE NEUTROPENIA 369 0.0056
379 LOWER GASTROINTESTINAL HAEMORRHAGE 41 0.0055
380 GASTRIC PERFORATION 15 0.0055
381 BLOOD ALKALINE PHOSPHATASE INCREASED 136 0.0055
382 GENERAL PHYSICAL HEALTH DETERIORATION 632 0.0055
383 OESOPHAGEAL ULCER 21 0.0055
384 ALTERED STATE OF CONSCIOUSNESS 118 0.0054
385 PNEUMONIA ASPIRATION 136 0.0054
386 CYTOMEGALOVIRUS INFECTION REACTIVATION 24 0.0054
387 PANCREATITIS 284 0.0054
388 DIARRHOEA 3454 0.0053
389 NEUTROPHIL COUNT DECREASED 218 0.0053
390 IRITIS 16 0.0053
391 KERATITIS 16 0.0053
392 LYMPHOCYTE COUNT DECREASED 93 0.0053
393 NEPHROPATHY TOXIC 59 0.0053
394 DECREASED APPETITE 1218 0.0052
395 PARAPLEGIA 15 0.0052
396 ATRIOVENTRICULAR BLOCK 40 0.0052
397 ERYSIPELAS 26 0.0052
398 LARGE INTESTINAL ULCER 14 0.0052
399 CARDIOMYOPATHY 76 0.0051
400 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 132 0.0051
401 GOITRE 21 0.0051
402 CHOLECYSTITIS ACUTE 29 0.0051
403 CYTOMEGALOVIRUS INFECTION 85 0.0051
404 EOSINOPHILIC PNEUMONIA 16 0.0051
405 GASTROENTERITIS 74 0.0051
406 FAECAL CALPROTECTIN INCREASED 16 0.0050
407 BLOOD CREATINE PHOSPHOKINASE INCREASED 145 0.0050
408 APPETITE DISORDER 33 0.0050
409 RESPIRATORY FAILURE 363 0.0050
410 ACUTE HEPATIC FAILURE 68 0.0050
411 NEUROLOGICAL SYMPTOM 28 0.0049
412 HYPOXIA 172 0.0049
413 GENERAL PHYSICAL CONDITION ABNORMAL 33 0.0049
414 STAPHYLOCOCCAL SEPSIS 24 0.0049
415 MUCOSAL INFLAMMATION 126 0.0048
416 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
417 ACUTE RESPIRATORY FAILURE 92 0.0048
418 KLEBSIELLA INFECTION 24 0.0047
419 SERUM FERRITIN INCREASED 25 0.0047
420 ACIDOSIS 36 0.0047
421 GAMMA-GLUTAMYLTRANSFERASE INCREASED 104 0.0047
422 ATYPICAL PNEUMONIA 14 0.0047
423 PNEUMOTHORAX 74 0.0047
424 CARDIAC FAILURE ACUTE 31 0.0046
425 PERIPHERAL ISCHAEMIA 19 0.0046
426 CARDIAC DYSFUNCTION 17 0.0046
427 RASH 1988 0.0046
428 UROSEPSIS 42 0.0045
429 SHOCK HAEMORRHAGIC 37 0.0045
430 NEOPLASM 52 0.0045
431 HAEMOPTYSIS 126 0.0045
432 RASH PRURITIC 244 0.0045
433 NEUTROPENIC SEPSIS 32 0.0045
434 HYPERBILIRUBINAEMIA 46 0.0044
435 PULMONARY EMBOLISM 422 0.0044
436 SINUS TACHYCARDIA 63 0.0044
437 KETOACIDOSIS 33 0.0044
438 DIABETES MELLITUS 335 0.0044
439 ATRIAL FLUTTER 35 0.0044
440 HYPOMAGNESAEMIA 61 0.0044
441 EXTRAVASATION 18 0.0044
442 HUMERUS FRACTURE 21 0.0044
443 LUNG ADENOCARCINOMA 13 0.0043
444 ABDOMINAL ABSCESS 19 0.0043
445 THROMBOCYTOPENIA 480 0.0043
446 MALNUTRITION 48 0.0043
447 RENAL TUBULAR NECROSIS 42 0.0043
448 SKIN INFECTION 48 0.0043
449 DEAFNESS NEUROSENSORY 14 0.0043
450 HYPERPYREXIA 18 0.0042
451 BLOOD DISORDER 34 0.0042
452 ANAEMIA 808 0.0042
453 INFUSION RELATED REACTION 279 0.0042
454 HEPATOCELLULAR CARCINOMA 32 0.0042
455 PYELONEPHRITIS 36 0.0042
456 PANCYTOPENIA 232 0.0041
457 CONJUNCTIVITIS 77 0.0041
458 HICCUPS 34 0.0041
459 ELECTROLYTE IMBALANCE 48 0.0041
460 LYMPHADENOPATHY 146 0.0041
461 HYPOCALCAEMIA 78 0.0041
462 CARDIOGENIC SHOCK 59 0.0041
463 PERICARDITIS 69 0.0041
464 UPPER GASTROINTESTINAL HAEMORRHAGE 69 0.0041
465 BILE DUCT STONE 13 0.0041
466 APPENDICITIS 38 0.0041
467 PRODUCT PREPARATION ERROR 83 0.0040
468 VASCULITIS 47 0.0040
469 NEOPLASM PROGRESSION 139 0.0040
470 ARTHRITIS 310 0.0039
471 HYPOVOLAEMIA 23 0.0039
472 DIPLOPIA 102 0.0039
473 PERITONITIS 81 0.0039
474 DIVERTICULUM INTESTINAL 17 0.0039
475 BRONCHOPULMONARY ASPERGILLOSIS 30 0.0039
476 SUPRAVENTRICULAR TACHYCARDIA 37 0.0039
477 RENAL DISORDER 179 0.0038
478 HYPERNATRAEMIA 19 0.0038
479 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 36 0.0038
480 CEREBRAL INFARCTION 92 0.0038
481 HYPOVOLAEMIC SHOCK 18 0.0038
482 KIDNEY TRANSPLANT REJECTION 18 0.0037
483 VASCULAR DEVICE INFECTION 17 0.0037
484 ACUTE CORONARY SYNDROME 31 0.0037
485 DERMATITIS BULLOUS 27 0.0037
486 HEPATIC NECROSIS 14 0.0037
487 PLEURISY 22 0.0037
488 BRONCHIOLITIS 13 0.0037
489 CEREBRAL ISCHAEMIA 19 0.0037
490 FACIAL PARESIS 13 0.0037
491 DEMYELINATION 15 0.0037
492 FIBRIN D DIMER INCREASED 13 0.0037
493 HERPES VIRUS INFECTION 21 0.0036
494 IMMUNE SYSTEM DISORDER 48 0.0036
495 JAUNDICE 98 0.0036
496 BLOOD CREATININE INCREASED 237 0.0036
497 PROTEINURIA 69 0.0036
498 BONE LESION 13 0.0036
499 NECROSIS 20 0.0036
500 RETINAL DETACHMENT 33 0.0036
501 CARDIOTOXICITY 32 0.0036
502 LEFT VENTRICULAR DYSFUNCTION 24 0.0036
503 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 83 0.0036
504 FLANK PAIN 33 0.0035
505 DELIRIUM 122 0.0035
506 ATRIAL FIBRILLATION 342 0.0035
507 LUNG DISORDER 172 0.0035
508 ACUTE RESPIRATORY DISTRESS SYNDROME 62 0.0035
509 ASPERGILLUS INFECTION 23 0.0035
510 METASTATIC NEOPLASM 15 0.0035
511 GENERALISED OEDEMA 43 0.0035
512 MONOPLEGIA 15 0.0034
513 STAPHYLOCOCCAL BACTERAEMIA 15 0.0034
514 TASTE DISORDER 70 0.0034
515 HEPATIC ENZYME INCREASED 235 0.0034
516 WEIGHT FLUCTUATION 36 0.0034
517 PNEUMONIA 1113 0.0034
518 CLOSTRIDIUM DIFFICILE INFECTION 75 0.0034
519 INCORRECT PRODUCT STORAGE 45 0.0034
520 HYPERKALAEMIA 118 0.0034
521 COLECTOMY 19 0.0034
522 ENDOCARDITIS 17 0.0033
523 RHABDOMYOLYSIS 138 0.0033
524 MUSCULAR WEAKNESS 376 0.0033
525 SHOCK 76 0.0033
526 HEPATIC PAIN 14 0.0033
527 PULMONARY TUBERCULOSIS 14 0.0033
528 CARDIAC FAILURE 263 0.0033
529 INTRACRANIAL PRESSURE INCREASED 18 0.0032
530 STOMATITIS 195 0.0032
531 PHOTOSENSITIVITY REACTION 53 0.0032
532 ORAL CANDIDIASIS 42 0.0032
533 CEREBRAL HAEMORRHAGE 114 0.0032
534 BRAIN NEOPLASM 29 0.0032
535 RENAL IMPAIRMENT 265 0.0032
536 SKIN REACTION 44 0.0031
537 HYDROCEPHALUS 17 0.0031
538 BLOOD URIC ACID INCREASED 18 0.0031
539 HAEMOLYSIS 24 0.0031
540 CYTOPENIA 38 0.0031
541 NEOPLASM MALIGNANT 207 0.0031
542 LIVER FUNCTION TEST ABNORMAL 90 0.0031
543 OFF LABEL USE 2701 0.0031
544 BLOOD SODIUM DECREASED 58 0.0031
545 PLATELET COUNT DECREASED 327 0.0031
546 LUNG INFILTRATION 27 0.0031
547 CHROMATURIA 69 0.0031
548 TRANSFUSION 32 0.0031
549 PANCREATIC DISORDER 15 0.0030
550 ATAXIA 36 0.0030
551 CORONAVIRUS INFECTION 20 0.0030
552 ASPIRATION 33 0.0030
553 HAEMORRHAGE INTRACRANIAL 45 0.0030
554 MELANOCYTIC NAEVUS 13 0.0030
555 DIVERTICULITIS 82 0.0030
556 HEPATOMEGALY 29 0.0029
557 HYPOPHAGIA 75 0.0029
558 NEUROPATHY PERIPHERAL 278 0.0029
559 CHILLS 340 0.0029
560 NEUROTOXICITY 50 0.0029
561 ACUTE MYOCARDIAL INFARCTION 84 0.0028
562 PRODUCT STORAGE ERROR 249 0.0028
563 BUNDLE BRANCH BLOCK RIGHT 13 0.0028
564 THERAPY PARTIAL RESPONDER 44 0.0028
565 ABDOMINAL TENDERNESS 14 0.0028
566 CIRCULATORY COLLAPSE 48 0.0028
567 NEUTROPENIA 382 0.0028
568 HYDRONEPHROSIS 21 0.0028
569 OEDEMA 152 0.0028
570 RENAL FAILURE 370 0.0028
571 CORONARY ARTERY STENOSIS 14 0.0028
572 BLOOD TESTOSTERONE DECREASED 19 0.0028
573 PULMONARY MASS 41 0.0027
574 LYMPHOEDEMA 19 0.0027
575 WOUND INFECTION 30 0.0027
576 FEMORAL NECK FRACTURE 14 0.0027
577 HAEMATURIA 93 0.0027
578 PANCREATITIS ACUTE 61 0.0027
579 LEUKOCYTOSIS 49 0.0027
580 PULMONARY HAEMORRHAGE 21 0.0027
581 HYPOTENSION 531 0.0026
582 COVID-19 PNEUMONIA 31 0.0026
583 ANAL FISTULA 14 0.0026
584 HERPES SIMPLEX 17 0.0026
585 PRURITUS 1002 0.0026
586 HEPATIC ENZYME ABNORMAL 13 0.0026
587 VENTRICULAR TACHYCARDIA 43 0.0026
588 DEVICE RELATED INFECTION 40 0.0026
589 DERMATITIS EXFOLIATIVE 13 0.0026
590 ANAL ABSCESS 14 0.0026
591 MELAENA 57 0.0026
592 CEREBRAL DISORDER 19 0.0026
593 MENTAL STATUS CHANGES 71 0.0026
594 PAPULE 18 0.0026
595 ESCHERICHIA INFECTION 21 0.0026
596 EPILEPSY 78 0.0025
597 INTESTINAL ISCHAEMIA 14 0.0025
598 ABDOMINAL PAIN 591 0.0025
599 HYPERKERATOSIS 14 0.0025
600 COLITIS ISCHAEMIC 17 0.0025
601 STREPTOCOCCAL INFECTION 14 0.0025
602 PARALYSIS 36 0.0025
603 WEIGHT DECREASED 695 0.0025
604 CELLULITIS 125 0.0025
605 RESPIRATORY DISTRESS 68 0.0025
606 ANURIA 21 0.0024
607 VOMITING 1144 0.0024
608 HAEMATOTOXICITY 23 0.0024
609 HAIR COLOUR CHANGES 30 0.0024
610 HEMIPLEGIA 20 0.0024
611 LIVER INJURY 59 0.0024
612 LEUKOPENIA 119 0.0024
613 POSTOPERATIVE WOUND INFECTION 16 0.0024
614 GRAFT VERSUS HOST DISEASE 17 0.0024
615 INTESTINAL OBSTRUCTION 89 0.0024
616 HYPERTHERMIA 18 0.0024
617 DISEASE PROGRESSION 278 0.0023
618 COLITIS ULCERATIVE 105 0.0023
619 GASTRIC ULCER HAEMORRHAGE 13 0.0023
620 HOSPICE CARE 23 0.0023
621 MACULAR OEDEMA 13 0.0023
622 GASTRIC ULCER 44 0.0023
623 SPLENOMEGALY 27 0.0023
624 FATIGUE 1777 0.0023
625 CONSTIPATION 493 0.0023
626 PHARYNGITIS 28 0.0023
627 CENTRAL NERVOUS SYSTEM LESION 31 0.0023
628 DECUBITUS ULCER 18 0.0022
629 INFLAMMATION 114 0.0022
630 EJECTION FRACTION DECREASED 34 0.0022
631 RASH PAPULAR 49 0.0022
632 HEMIPARESIS 37 0.0022
633 DYSPHAGIA 207 0.0022
634 PRESYNCOPE 53 0.0022
635 JOINT EFFUSION 15 0.0022
636 GASTRIC HAEMORRHAGE 25 0.0022
637 GASTROINTESTINAL INFLAMMATION 17 0.0022
638 GROIN PAIN 19 0.0022
639 MOTOR DYSFUNCTION 22 0.0022
640 DERMATITIS ALLERGIC 27 0.0021
641 RENAL CYST 17 0.0021
642 CANDIDA INFECTION 36 0.0021
643 PSEUDOMONAS INFECTION 18 0.0021
644 GASTROINTESTINAL DISORDER 187 0.0021
645 GASTROINTESTINAL HAEMORRHAGE 174 0.0021
646 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
647 ASTHENIA 776 0.0021
648 FAECES SOFT 15 0.0021
649 DEEP VEIN THROMBOSIS 134 0.0021
650 MYELOSUPPRESSION 74 0.0021
651 HAEMORRHOIDS 40 0.0020
652 NIGHT SWEATS 66 0.0020
653 DEPRESSED LEVEL OF CONSCIOUSNESS 81 0.0020
654 SYNCOPE 204 0.0020
655 REBOUND EFFECT 23 0.0020
656 BLOOD ALBUMIN DECREASED 16 0.0020
657 GASTROINTESTINAL INFECTION 18 0.0020
658 NODULE 26 0.0020
659 CARDIAC ARREST 164 0.0020
660 LYMPHOPENIA 28 0.0020
661 HEPATIC CIRRHOSIS 37 0.0020
662 CARDIO-RESPIRATORY ARREST 82 0.0020
663 DRY MOUTH 159 0.0020
664 THIRST 35 0.0020
665 NERVOUS SYSTEM DISORDER 61 0.0020
666 APHASIA 59 0.0020
667 OEDEMA PERIPHERAL 238 0.0020
668 THROMBOTIC MICROANGIOPATHY 19 0.0019
669 SPINAL COMPRESSION FRACTURE 16 0.0019
670 DYSPNOEA 1092 0.0019
671 FEEDING DISORDER 39 0.0019
672 SQUAMOUS CELL CARCINOMA 18 0.0019
673 RECTAL HAEMORRHAGE 82 0.0019
674 CONFUSIONAL STATE 307 0.0019
675 FACE OEDEMA 32 0.0019
676 SKIN LESION 52 0.0019
677 HAEMATOCHEZIA 104 0.0019
678 ANAPHYLACTIC REACTION 104 0.0019
679 EATING DISORDER 40 0.0019
680 PULMONARY OEDEMA 84 0.0019
681 DEAFNESS 49 0.0019
682 NAUSEA 1478 0.0019
683 DYSPNOEA EXERTIONAL 70 0.0019
684 URINARY TRACT INFECTION 316 0.0019
685 IRON DEFICIENCY ANAEMIA 17 0.0018
686 BACTERIAL INFECTION 34 0.0018
687 NEPHROPATHY 17 0.0018
688 SUBDURAL HAEMATOMA 26 0.0018
689 BODY TEMPERATURE INCREASED 37 0.0018
690 MUSCULOSKELETAL CHEST PAIN 28 0.0018
691 URINARY RETENTION 60 0.0018
692 PRODUCT USE IN UNAPPROVED INDICATION 445 0.0018
693 DRUG RESISTANCE 46 0.0018
694 MASS 25 0.0018
695 BACK PAIN 415 0.0018
696 METABOLIC ACIDOSIS 57 0.0018
697 RASH GENERALISED 46 0.0018
698 MALAISE 779 0.0018
699 RASH MACULAR 62 0.0018
700 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 92 0.0018
701 MYALGIA 297 0.0017
702 COAGULOPATHY 29 0.0017
703 INFECTION 250 0.0017
704 HYPOGLYCAEMIA 83 0.0017
705 ANAPHYLACTIC SHOCK 44 0.0017
706 SKIN ULCER 44 0.0017
707 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 93 0.0017
708 COGNITIVE DISORDER 79 0.0017
709 SEIZURE 194 0.0017
710 BONE MARROW FAILURE 34 0.0017
711 NEUTROPHIL COUNT INCREASED 17 0.0017
712 RENAL FAILURE ACUTE 70 0.0016
713 BLOOD TEST ABNORMAL 23 0.0016
714 VITREOUS FLOATERS 16 0.0016
715 THERAPY NON-RESPONDER 73 0.0016
716 TACHYCARDIA 144 0.0016
717 TYPE 2 DIABETES MELLITUS 54 0.0016
718 HOSPITALISATION 245 0.0016
719 SPINAL OSTEOARTHRITIS 14 0.0016
720 ABNORMAL FAECES 13 0.0016
721 HERPES ZOSTER 91 0.0016
722 SUBARACHNOID HAEMORRHAGE 16 0.0016
723 SINUS BRADYCARDIA 15 0.0016
724 ORTHOSTATIC HYPOTENSION 27 0.0015
725 RESPIRATORY TRACT INFECTION 40 0.0015
726 INFLAMMATORY BOWEL DISEASE 15 0.0015
727 DYSURIA 56 0.0015
728 ARRHYTHMIA 72 0.0015
729 INCREASED APPETITE 29 0.0015
730 ISCHAEMIC STROKE 27 0.0015
731 STATUS EPILEPTICUS 17 0.0015
732 MULTI-ORGAN FAILURE 26 0.0015
733 HYPOTONIA 15 0.0015
734 COUGH 420 0.0015
735 VERTIGO 91 0.0015
736 PRODUCTIVE COUGH 71 0.0015
737 INFLUENZA LIKE ILLNESS 121 0.0015
738 EYE INFLAMMATION 14 0.0015
739 GASTROINTESTINAL PAIN 16 0.0015
740 SPINAL FRACTURE 29 0.0014
741 ANAL INCONTINENCE 13 0.0014
742 BLOOD PRESSURE DECREASED 96 0.0014
743 HYPERTENSIVE CRISIS 16 0.0014
744 ARTHRALGIA 598 0.0014
745 STAPHYLOCOCCAL INFECTION 47 0.0014
746 RASH ERYTHEMATOUS 68 0.0014
747 MUSCLE ATROPHY 18 0.0014
748 CYSTITIS 45 0.0014
749 BREAST PAIN 15 0.0014
750 NEURALGIA 34 0.0014
751 ORAL PAIN 31 0.0014
752 MYELODYSPLASTIC SYNDROME 20 0.0014
753 HAEMATEMESIS 35 0.0014
754 RESPIRATORY DISORDER 41 0.0014
755 SPINAL PAIN 16 0.0014
756 RHEUMATOID ARTHRITIS 152 0.0013
757 OXYGEN SATURATION DECREASED 75 0.0013
758 HEADACHE 829 0.0013
759 UPPER RESPIRATORY TRACT INFECTION 61 0.0013
760 COVID-19 231 0.0013
761 MOVEMENT DISORDER 42 0.0013
762 HYPERTENSION 275 0.0013
763 EMPHYSEMA 13 0.0013
764 HYPOTHERMIA 13 0.0013
765 MUSCULOSKELETAL PAIN 67 0.0013
766 WHITE BLOOD CELL COUNT DECREASED 137 0.0013
767 DISORIENTATION 50 0.0013
768 ECZEMA 66 0.0013
769 VENTRICULAR FIBRILLATION 14 0.0013
770 MYOCLONUS 15 0.0013
771 NECK PAIN 70 0.0013
772 PRODUCT ADMINISTRATION ERROR 25 0.0012
773 HAEMOGLOBIN DECREASED 126 0.0012
774 BLINDNESS 50 0.0012
775 TOXICITY TO VARIOUS AGENTS 206 0.0012
776 ANGINA PECTORIS 35 0.0012
777 BONE PAIN 71 0.0012
778 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
779 PEMPHIGUS 15 0.0012
780 DYSARTHRIA 45 0.0012
781 HEPATIC STEATOSIS 22 0.0012
782 BLOOD IRON DECREASED 14 0.0012
783 WHITE BLOOD CELL COUNT INCREASED 45 0.0012
784 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
785 LOWER RESPIRATORY TRACT INFECTION 52 0.0011
786 DRY EYE 57 0.0011
787 BLISTER 64 0.0011
788 GAIT INABILITY 38 0.0011
789 ADVERSE REACTION 15 0.0011
790 LETHARGY 65 0.0011
791 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 33 0.0011
792 RETCHING 24 0.0011
793 AGEUSIA 28 0.0011
794 ABDOMINAL DISTENSION 117 0.0011
795 CHEST PAIN 206 0.0011
796 LACTIC ACIDOSIS 36 0.0011
797 FRACTURE 21 0.0011
798 ERYTHEMA 228 0.0011
799 IMPAIRED GASTRIC EMPTYING 15 0.0011
800 POST PROCEDURAL COMPLICATION 21 0.0011
801 VISUAL ACUITY REDUCED 36 0.0011
802 HYPERSOMNIA 31 0.0011
803 VISION BLURRED 147 0.0011
804 ULCER 17 0.0011
805 ABDOMINAL PAIN LOWER 27 0.0011
806 ABSCESS 17 0.0011
807 EYE DISORDER 35 0.0011
808 HAEMATOCRIT DECREASED 21 0.0011
809 ABDOMINAL PAIN UPPER 218 0.0011
810 THROMBOSIS 85 0.0011
811 PULMONARY HYPERTENSION 22 0.0011
812 BRONCHOSPASM 15 0.0011
813 RESTLESSNESS 38 0.0010
814 BASAL CELL CARCINOMA 16 0.0010
815 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
816 DYSPHONIA 59 0.0010
817 FREQUENT BOWEL MOVEMENTS 27 0.0010
818 OSTEOMYELITIS 18 0.0010
819 BLINDNESS UNILATERAL 14 0.0010
820 TOOTH DISORDER 22 0.0010
821 BLOOD POTASSIUM INCREASED 16 0.0010
822 VISUAL IMPAIRMENT 122 0.0010
823 FEELING COLD 27 0.0010
824 DEMENTIA 27 0.0010
825 COLD SWEAT 17 0.0010
826 BLOOD POTASSIUM DECREASED 29 0.0010
827 CYANOSIS 15 0.0010
828 MOUTH ULCERATION 20 0.0009
829 CARDIOVASCULAR DISORDER 24 0.0009
830 CHOLELITHIASIS 31 0.0009
831 SOMNOLENCE 190 0.0009
832 HYPOAESTHESIA 141 0.0009
833 PULMONARY FIBROSIS 18 0.0009
834 HAEMATOMA 24 0.0009
835 EAR PAIN 18 0.0009
836 ORAL HERPES 18 0.0009
837 CEREBROVASCULAR ACCIDENT 156 0.0009
838 MANIA 15 0.0009
839 URINARY INCONTINENCE 27 0.0009
840 SLEEP DISORDER 64 0.0009
841 PHOTOPHOBIA 17 0.0009
842 ACUTE MYELOID LEUKAEMIA 14 0.0009
843 PARAESTHESIA 141 0.0009
844 BLOOD UREA INCREASED 15 0.0009
845 COMA 42 0.0009
846 LOSS OF CONSCIOUSNESS 113 0.0009
847 GAIT DISTURBANCE 167 0.0009
848 VIRAL INFECTION 29 0.0009
849 DRUG INTOLERANCE 84 0.0009
850 FALL 288 0.0009
851 HYPERSENSITIVITY 160 0.0009
852 URTICARIA 143 0.0009
853 OROPHARYNGEAL PAIN 79 0.0009
854 BRONCHITIS 63 0.0009
855 FEMUR FRACTURE 26 0.0008
856 PRURITUS GENERALISED 18 0.0008
857 DRY SKIN 111 0.0008
858 SKIN DISCOLOURATION 38 0.0008
859 INSOMNIA 220 0.0008
860 EPISTAXIS 61 0.0008
861 KIDNEY INFECTION 16 0.0008
862 MYOCARDIAL INFARCTION 142 0.0008
863 ADVERSE DRUG REACTION 73 0.0008
864 BLOOD GLUCOSE ABNORMAL 15 0.0008
865 DYSGEUSIA 60 0.0008
866 SPEECH DISORDER 42 0.0008
867 CORONARY ARTERY DISEASE 24 0.0008
868 HEAD DISCOMFORT 14 0.0008
869 HYPOACUSIS 34 0.0008
870 OCULAR HYPERAEMIA 37 0.0008
871 CONDITION AGGRAVATED 237 0.0008
872 LABORATORY TEST ABNORMAL 23 0.0008
873 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
874 RED BLOOD CELL COUNT DECREASED 22 0.0008
875 POLLAKIURIA 32 0.0008
876 PAIN IN EXTREMITY 225 0.0008
877 EYE PAIN 43 0.0008
878 TINNITUS 35 0.0008
879 SKIN EXFOLIATION 64 0.0008
880 HYPERHIDROSIS 97 0.0008
881 DYSPEPSIA 73 0.0007
882 PERIPHERAL SWELLING 114 0.0007
883 PAIN 454 0.0007
884 FAECES DISCOLOURED 16 0.0007
885 PALLOR 20 0.0007
886 RIB FRACTURE 15 0.0007
887 HAEMORRHAGE 76 0.0007
888 CARDIAC DISORDER 68 0.0007
889 CHRONIC KIDNEY DISEASE 55 0.0007
890 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 24 0.0007
891 DIZZINESS 353 0.0007
892 OSTEONECROSIS OF JAW 17 0.0007
893 CONTUSION 66 0.0007
894 MUSCULOSKELETAL STIFFNESS 60 0.0007
895 HIP FRACTURE 22 0.0007
896 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
897 BRADYCARDIA 36 0.0007
898 INFLUENZA 75 0.0007
899 WEIGHT INCREASED 150 0.0007
900 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
901 PSORIASIS 87 0.0007
902 PSORIATIC ARTHROPATHY 27 0.0007
903 THERAPY CESSATION 34 0.0007
904 SINUSITIS 67 0.0007
905 DYSSTASIA 19 0.0007
906 CARDIAC FAILURE CONGESTIVE 52 0.0006
907 FULL BLOOD COUNT DECREASED 13 0.0006
908 HOT FLUSH 48 0.0006
909 AMNESIA 41 0.0006
910 FUNGAL INFECTION 21 0.0006
911 SWELLING FACE 40 0.0006
912 JOINT STIFFNESS 16 0.0006
913 TREMOR 100 0.0006
914 DEPRESSION 137 0.0006
915 PRODUCT USE ISSUE 113 0.0006
916 ALOPECIA 117 0.0006
917 TREATMENT NONCOMPLIANCE 32 0.0006
918 HEPATIC CANCER 14 0.0006
919 FLATULENCE 33 0.0006
920 LIMB DISCOMFORT 18 0.0006
921 MUSCLE SPASMS 105 0.0006
922 CATARACT 34 0.0006
923 LIP SWELLING 19 0.0006
924 SWELLING 53 0.0006
925 CONVULSION 32 0.0006
926 GASTROOESOPHAGEAL REFLUX DISEASE 45 0.0006
927 JOINT SWELLING 67 0.0006
928 CHEST DISCOMFORT 56 0.0005
929 RESPIRATORY ARREST 15 0.0005
930 PSYCHOTIC DISORDER 16 0.0005
931 MEMORY IMPAIRMENT 74 0.0005
932 DRUG INEFFECTIVE 708 0.0005
933 IRRITABILITY 32 0.0005
934 LACRIMATION INCREASED 16 0.0005
935 RHINORRHOEA 34 0.0005
936 ABDOMINAL DISCOMFORT 88 0.0005
937 OSTEOARTHRITIS 22 0.0005
938 HEART RATE INCREASED 51 0.0005
939 ILLNESS 53 0.0005
940 EYE SWELLING 19 0.0005
941 DISCOMFORT 31 0.0005
942 DISEASE RECURRENCE 24 0.0005
943 ARTHROPATHY 28 0.0005
944 WOUND 14 0.0005
945 FLUID RETENTION 25 0.0005
946 FEELING HOT 30 0.0005
947 IMPAIRED HEALING 16 0.0005
948 BALANCE DISORDER 42 0.0005
949 BLOOD PRESSURE INCREASED 72 0.0005
950 ANXIETY 134 0.0005
951 NO ADVERSE EVENT 85 0.0005
952 GASTRIC DISORDER 16 0.0005
953 HALLUCINATION 35 0.0005
954 NASOPHARYNGITIS 85 0.0005
955 ILL-DEFINED DISORDER 28 0.0005
956 EYE PRURITUS 15 0.0004
957 WHEEZING 26 0.0004
958 DEPRESSED MOOD 23 0.0004
959 DRUG ADMINISTRATION ERROR 13 0.0004
960 FLUSHING 43 0.0004
961 DRUG INTERACTION 66 0.0004
962 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 29 0.0004
963 PALPITATIONS 47 0.0004
964 HEART RATE DECREASED 14 0.0004
965 ACNE 30 0.0004
966 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 19 0.0004
967 MENTAL DISORDER 17 0.0004
968 MOBILITY DECREASED 28 0.0004
969 LUNG NEOPLASM MALIGNANT 16 0.0004
970 TREATMENT FAILURE 32 0.0004
971 ANGIOEDEMA 17 0.0004
972 THERAPEUTIC RESPONSE DECREASED 23 0.0004
973 DISTURBANCE IN ATTENTION 20 0.0004
974 SURGERY 20 0.0003
975 BLOOD GLUCOSE INCREASED 63 0.0003
976 ABNORMAL BEHAVIOUR 13 0.0003
977 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 55 0.0003
978 PRODUCT DOSE OMISSION ISSUE 87 0.0003
979 MIGRAINE 27 0.0003
980 NASAL CONGESTION 16 0.0003
981 BURNING SENSATION 19 0.0003
982 MEDICATION ERROR 15 0.0003
983 ASTHMA 27 0.0002
984 EYE IRRITATION 13 0.0002
985 AGITATION 16 0.0002
986 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
987 THERAPY INTERRUPTED 14 0.0002
988 FEELING ABNORMAL 46 0.0002
989 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
990 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
991 OVERDOSE 35 0.0002
992 DRUG DOSE OMISSION 20 0.0001
993 INCORRECT DOSE ADMINISTERED 24 0.0001